โ† All deals

Ayatris, Inc.

Other Health CareBiotechnologyOrgan-on-ChipDrug Discovery
๐Ÿ“ Frederick, MD, United States
StreetZero Signal 55
Be the first to signal interest

About Ayatris, Inc.

Ayatris Inc. is a Maryland-based biotechnology company developing advanced organoid and organ-on-chip technologies for drug discovery, disease modeling, and precision medicine. Through its proprietary and licensed technologies, Ayatris is building scalable, physiologically relevant platforms that help researchers and industry partners accelerate therapeutic development while enabling more human-relevant approaches to biomedical research. The company is headquartered in Frederick, Maryland. Supported by the TEDCO Equitech Growth Fund, Ayatris is building an integrated research infrastructure that combines organoid science, organ-on-chip technologies, advanced imaging, and translational research.

LATEST FUNDINGPrivate Placement
$100K
Announced 2026-11-19
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Ayatris, Inc..

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Awarded $1,000,000 TEDCO Equitech Growth Fund grant for organ-on-chip infrastructure
  • Headquartered in Frederick, Maryland and focused on organoid technologies
  • Building platforms for drug discovery, disease modeling, and precision medicine
  • Combining organoid science with advanced imaging and translational research

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account